Cannabinoids in hematologic malignancies: mechanisms and therapeutic potential for overcoming drug resistance
Hematologic malignancies are highly heterogeneous diseases in which the emergence of therapy resistance remains a major obstacle to durable clinical benefit. Cannabinoids, acting through the endocannabinoid system, have drawn increasing interest because of their potential to modulate multiple resistance-associated pa...